Skip to main content
OpenTrials

Clinical trial condition

Triple Negative Breast Neoplasms

Explore clinical trials studying Triple Negative Breast Neoplasms. Study availability and eligibility vary by location and protocol.

819 public trials 296 recruiting studies
Refine in advanced search Browse all conditions

Triple Negative Breast Neoplasms trial results

Completed

A Phase 1/2 Study of CYT-0851 in B-Cell Malignancies and Advanced Solid Tumors

NCT03997968

Conditions
Adnexal Diseases, Blood Protein Disorders, Breast Cancer, +68 more
Locations
  • University of California San Francisco San Francisco, California, United States
  • Stanford Comprehensive Cancer Center Stanford, California, United States
  • Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States
  • Florida Cancer Specialists and Research Institute Sarasota, Florida, United States
View all 16 locations
View Trial Details
Completed

Study to Assess Safety, Tolerability and Clinical Activity of BGB-290 in Combination With Temozolomide (TMZ) in Participants With Locally Advanced or Metastatic Solid Tumors

NCT03150810

Conditions
Adnexal Diseases, Breast Diseases, Breast Neoplasms, +39 more
Locations
  • Start Midwest Grand Rapids, Michigan, United States
  • Washington University in St Louis St Louis, Missouri, United States
  • Mount Sinai Prime New York, United States
  • Montefiore Medical Park At Eastchester Einstein Campus The Bronx, New York, United States
View all 22 locations
View Trial Details
Completed

Carboplatin With or Without Atezolizumab in Treating Patients With Stage IV Triple Negative Breast Cancer

NCT03206203

Conditions
Breast Diseases, Breast Neoplasms, HER2 Negative, +8 more
Locations
  • Georgetown University Lombardi Comprehensive Cancer Center Washington D.C., District of Columbia, United States
  • Indiana University Health Melvin Bren Simon Cancer Center Indianapolis, Indiana, United States
  • Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States
  • University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States
View Trial Details
Completed

Comparison of Biological Features Between pN0 Triple Negative Breast Tumours With Size < or = 10 mm (pT1a/b) Versus pT1c T2 < or = 30 mm

NCT02266420

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations
  • Institut de Cancerologie de L'Ouest - Site Paul Papin Angers, France
  • Centre Francois Baclesse Caen, France
  • Centre Jean Perrin Clermont-Ferrand, France
  • CH Emile ROUX Le Puy-en-Velay, France
View Trial Details
Completed

OXEL: Immune Checkpoint or Capecitabine or Combination Therapy as Adjuvant Therapy for TNBC With Residual Disease

NCT03487666

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations
  • MedStar Georgetown University Hospital Washington D.C., District of Columbia, United States
  • MedStar Washington Hospital Center Washington D.C., District of Columbia, United States
  • University of Chicago Chicago, Illinois, United States
  • John Theurer Cancer Center at Hackensack University Medical Center Hackensack, New Jersey, United States
View Trial Details
Completed

Galinpepimut-S in Combination With Pembrolizumab in Patients With Selected Advanced Cancers

NCT03761914

Conditions
Acute Myelogenous Leukemia, Adnexal Diseases, Breast Diseases, +45 more
Locations
  • St. Joseph Heritage Healthcare Santa Rosa, California, United States
  • Innovative Clinical Research Institute (ICRI) Whittier, California, United States
  • Miami Cancer Institute at Baptist Health, Inc. Miami, Florida, United States
  • Memorial Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States
View Trial Details
Completed

Phase 1 Dose Escalation Study for VIP236 in Patients With Advanced Cancer

NCT05712889

Conditions
Adnexal Diseases, Biliary Tract Diseases, Biliary Tract Neoplasms, +43 more
Locations
  • Honor Health Scottsdale, Arizona, United States
  • NEXT Austin Austin, Texas, United States
  • NEXT Oncology San Antonio San Antonio, Texas, United States
  • Macquarie University Macquarie Park, New South Wales, Australia
View Trial Details

Related conditions